Pulmonary rehabilitation in patients with interstitial lung disease – An useful therapeutic option?

P. Huppmann, B. Sczepanski, M. Boensch, S. Winterkamp, U. Schönheit-Kenn, C. Neurohr, J. Behr, K. Kenn (Munich, Schoenau am Koenigssee, Bochum, Germany)

Source: Annual Congress 2011 - Pulmonary rehabilitation: looking at alternative approaches and alternative populations beyond COPD
Disease area: Interstitial lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Huppmann, B. Sczepanski, M. Boensch, S. Winterkamp, U. Schönheit-Kenn, C. Neurohr, J. Behr, K. Kenn (Munich, Schoenau am Koenigssee, Bochum, Germany). Pulmonary rehabilitation in patients with interstitial lung disease – An useful therapeutic option?. Eur Respir J 2011; 38: Suppl. 55, 4812

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Identifying pulmonary hypertension in patients with interstitial lung disease – Evaluating an unmet need
Source: Annual Congress 2010 - Pulmonary circulation III
Year: 2010

Postoperative predicting value of lung function in patients with lung cancer – Fortune-telling or reality? Evaluation after surgical treatment
Source: Annual Congress 2011 - Lung function today and tomorrow II
Year: 2011

Real-life experience with pirfenidon in idiopathic pulmonary fibrosis: Does early treatment start predict better therapy adherence?
Source: International Congress 2015 – IPF: from bench to bedside
Year: 2015


Assessment of ventilation inhomogeneity in patients with alpha-1-antitrypsin deficiency – A useful tool for monitoring early lung disease
Source: Annual Congress 2012 - New understanding of childhood lung disease through physiological measurement
Year: 2012

Is sildenafil an effective bridging therapy to lung transplantation for patients with pulmonary hypertension in the setting of lung disease?
Source: International Congress 2015 – Pulmonary hypertension in lung disease
Year: 2015

Halotherapy – A possible method to enhance airway treatment on patients with obstructive pathology
Source: Annual Congress 2012 - Treatment of asthma, bronchiectasis and cough: inhaler use
Year: 2012

Pulmonary rehabilitation in advanced lung cancer patients during chemotherapy – Preliminary report
Source: Annual Congress 2012 - The best posters in pulmonary rehabilitation and chronic care
Year: 2012

Effects of pulmonary rehabilitation in patients with severe COPD in comparison to patients with severe interstitial lung disease
Source: Annual Congress 2013 –The best posters in pulmonary rehabilitation
Year: 2013


Efficacy of pulmonary rehabilitation in patients with interstitial lung disease
Source: Annual Congress 2012 - The best posters in pulmonary rehabilitation and chronic care
Year: 2012


What (and how) do we attain by performing surgical lung biopsy for interstitial lung disease?
Source: International Congress 2015 – Interstitial lung diseases II
Year: 2015


The value of a specialist nurse-lead interstitial lung disease clinic, patients’ views
Source: International Congress 2015 – Kaleidoscope of nursing research
Year: 2015


Current and future therapeutic approaches in idiopathic pulmonary fibrosis
Source: Eur Respir J 2005; 26: 693-703
Year: 2005



Biofeedback for improving the effectiveness of pulmonary rehabilitation exercise in patients with chronic obstructive pulmonary disease
Source: International Congress 2015 – Latest insights into pulmonary rehabilitation
Year: 2015

Surgical lung biopsy – Gold standard for diagnosis of idiopathic interstitial pneumonia?
Source: Annual Congress 2012 - New insights in the clinical management of lung diseases
Year: 2012

The effectiveness of anti-inflammatory therapy for chronic obstructive pulmonary disease complicated by ischemic heart disease (new medication - new opportunities)
Source: International Congress 2014 – Comorbidities
Year: 2014


Treatment of combined pulmonary fibrosis and emphysema
Source: International Congress 2016 – Novel avenues in the treatment of COPD II
Year: 2016

PROFILEing idiopathic pulmonary fibrosis: rethinking biomarker discovery
Source: Eur Respir Rev 2013; 22: 148-152
Year: 2013



COPD pulmonary rehabilitation - good enough for ILD patients?
Source: International Congress 2018 – Chronic lung disease : effects of rehabilitation interventions on functional outcomes in patients
Year: 2018

Postoperative complications after pneumonectomy in lung cancer patients – Whether lung function can act as a predictor?
Source: Annual Congress 2010 - Diagnostic and therapeutic problems in surgical oncology
Year: 2010


Pulmonary rehabilitation for bronchiectasis: if not now, when?
Source: Eur Respir J, 53 (1) 1802474; 10.1183/13993003.02474-2018
Year: 2019